Long term Hepatitis B surface antigen decay in HIV-1/HBV coinfected adults initiating a tenofovir containing regimen
Journal of Clinical Microbiology, 07/05/2012Tuaillon E et al.
The mean HBsAg decay was 0.38 Log10 IU/ml/year (95% CI: 0.71–0.05) in 18 patients with sustained plasma HIV–1 RNA suppression and 0.15 Log10 IU/ml/year (0.21–0.09) in 12 patients experiencing HIV–1 virologic failure due to suboptimal adherence to ARV (p=0.17). They estimated that six patients will attain HBsAg value below 10 IU/ml after ten years of treatment.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.